MedPath
NMPA Approval

Omeprazole and Sodium Bicarbonate for Suspension(II)

国药准字H20253507

March 4, 2025

Drug Information

奥美拉唑碳酸氢钠干混悬剂(Ⅱ)

口服混悬剂

每袋含奥美拉唑40mg和碳酸氢钠1680mg

化学药品

March 4, 2025

Company Information

Applicant Company

中国(上海)自由贸易试验区新金桥路905号

Manufacturing Company

中国(上海)自由贸易试验区新金桥路905号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥美拉唑碳酸氢钠干混悬剂(Ⅱ) - NMPA 批准文号 | MedPath